Author

C. H. Marquette

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. Paquet· 2 shared K. Lebrigand· 2 shared P. Barbry· 2 shared S. Leroy· 2 shared A. Cavard· 1 shared B. Crestani· 1 shared B. Marcet· 1 shared B. MariiD· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Paquet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-cell RNA sequencing reveals novel cell differentiation dynamics during human airway epithelium regeneration

S. Ruiz Garcia, M. Deprez, K. Lebrigand, A. Paquet, A. Cavard, M.-J. Arguel, V. Magnone, I. Caballero, S. Leroy, C. H. Marquette, B. Marcet, P. Barbry, L.-E. Zaragosi

This study uses single-cell RNA sequencing to uncover differentiation dynamics and cell trajectories in human airway epithelium regeneration, identifying novel cell subpopulations and signaling pathways involved.

bioRxiv · Oct 24, 2018Cell Biology

Targeting the DNM3OS / miR-199a~214 cluster for the treatment of fibroproliferative diseases

G. Savary, M. Buscot, E. Dewaeles, S. Diazzi, N. Nottet, E. Courcot, J. Fassy, K. Lebrigand, I. S. Henaoui, N. Martis, C. Van der Hauwaert, S. Leroy, L. Plantier, A. Paquet, C. L. Lino Cardenas, , N. Pottier

This study identifies DNM3OS as a key regulator of fibroblast activation via miRNAs, offering a therapeutic target for fibrotic diseases like IPF.

bioRxiv · Jan 4, 2018 · PreprintPathology